Investor's Business Daily on MSN
AstraZeneca, In A Buy Zone, Makes A Big Breast Cancer Splash
AstraZeneca's Enhertu could help some breast cancer patients avoid surgery, according to a study unveiled Saturday at ESMO.
AstraZeneca and Daiichi Sankyo’s star drug Enhertu has delivered a double knockout, showing its ability to stave off early ...
New generation of Antibody-Drug Conjugates (ADCs) shows unprecedented promise in early-stage disease
In a landmark moment at the ESMO Congress 2025, pivotal studies have unveiled compelling evidence that a new class of anti-cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results